U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Pediatric Advisory Committee
  5. Presentations for the May 11, 2018 Joint Meeting of the Pediatric and Endocrinologic and Metabolic Drugs Advisory Committees
  1. Pediatric Advisory Committee

Presentations for the May 11, 2018 Joint Meeting of the Pediatric and Endocrinologic and Metabolic Drugs Advisory Committees

  1. Achondroplasia
    Smita B. Abraham, M.D.
    Office of New Drugs, Division of Metabolism and Endocrinology Products
  2. Additional Safeguards for Children in Clinical Investigations, 21 CFR 50 Subpart D
    Donna L. Snyder, M.D., F.A.A.P
    FDA Office of Pediatric Therapeutics

 

Back to Top